Rol del cardiólogo en el manejo de pacientes oncológicos. ¿Dónde estamos y a donde debemos ir?

• Paredes-Paucar, Cynthia ^[1] ; López-Fernández, Teresa ^[2]
  1. [1] Instituto Nacional de Cardiología

     Instituto Nacional de Cardiología

     México

     
  2. [2] Hospital Universitario La Paz

     Hospital Universitario La Paz

     Madrid, España

     
• Localización: Revista Peruanos de Cardiología y Cirugía Cardiovascular, ISSN-e 2708-7212, Vol. 2, Nº. 2, 2021, págs. 103-111
• Idioma: español
• DOI: 10.47487/apcyccv.v2i2.140
• Títulos paralelos:
  • Role of the cardiologist in the management of oncology patients. Where are we standing, and what to expect in the future?
• Enlaces
  • Texto completo
• Dialnet Métricas: 1 Cita
• Resumen
  • español

    Las enfermedades cardiovasculares y las enfermedades oncológicas constituyen la primera y segunda causa de muerte a nivel mundial. Los pacientes oncológicos tienen más riesgo de muerte cardiovascular, y los pacientes cardiacos tienen más riesgo de cáncer, y esta interrelación va más allá de la toxicidad relacionado al tratamiento oncológico. La cardio-oncología surge como subespecialidad capaz de manejar las complicaciones cardiovasculares en pacientes con cáncer. Entre ellas, la disfunción cardiaca relacionada con antitumorales es una de las más temidas, y requiere una estratificación, diagnóstico, tratamiento y seguimiento oportuno. La creación de servicios cardio-oncológicos es una realidad que debemos construir a fin de cambiar nuestra práctica clínica y política sanitaria actual, con claras implicaciones a futuro.

  • English

    Cardiovascular and oncological diseases are the main causes of death worldwide. Cancer patients have an increased risk of cardiovascular diseases but, at the same time cardiovascular patients experience a higher risk of cancer. This relationship goes beyond the toxicity concerning cancer treatment. Cardio-oncology goal is to facilitate cancer therapy by implementing preventive strategies that allow early diagnosis and treatment of potential cancer therapy-induced cardiovascular complications, being heart failure the most fearest one. The creation of Cardio-oncology services has the potential to impact daily clinical practice and public health, with clear implications for the future.

• Referencias bibliográficas
  • Health at a Glance 2019. OECD Indicators. [internet]. OECD.org [Publicado 07 de noviembre, 2019. Última visita 30 de abril 2021]. Disponible...
  • Análisis de situación de salud del Perú 2019. [internet]. Centro Nacional de Epidemiología, Prevención y Control de enfermedades. [Publicado...
  • Cardinale D. A new frontier: cardio-oncology. Cardiologia [Internet]. 1996; 41:887-91.
  • Cardinale D, Caruso V, Cipolla CM. The breast cancer patient in the cardioncology unit. J Thorac Dis 2018 [Internet]. Dec;10(Suppl 35): S4306-S4322....
  • Meijers WC, Rudolf A. de Boer. Common risk factors for heart failure and cancer. Cardiovasc Res [Internet]. 2019 Apr 15;115(5):844-853. DOI:...
  • Moslehi J, Zhang Q, Moore KJ. Crosstalk Between the Heart and Cancer Beyond Drug Toxicity. Circulation [Internet]. 2020 Aug 18;142(7):684-687....
  • López-Fernández T, García AM, Santaballa Beltrán A, et al. Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations....
  • Sturgeon KM, Deng L, Bluethmann SM, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart...
  • MacDonald MR, Petrie MC, Varyani F, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure:...
  • Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer Viewpoint of the IARC Working Group. N Engl J Med [Internet]. 2016...
  • Libby P, Sidlow R, Lin AE, et al. Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: Review Topic of the Week....
  • Poynter JN, Gruber SB, Higgins P, et al. Statins and the risk of colorectal cancer. N Engl J Med [Internet]. 2005 May 26;352(21):2184-92....
  • Lancellotti P, Marechal P, Donis N, et al. Inflammation, cardiovascular disease, and cancer: a common link with far-reaching implications....
  • Van Kruijsdijk RC, van der Graaf Y, Peeters PH, et al. Cancer risk in patients with manifest vascular disease: effects of smoking, obesity,...
  • Hasin T, Gerber Y, Weston SA, Jiang R, et al. Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer. JACC...
  • Van’t Klooster CC, Ridker PM, Hjortnaes J, et al. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular...
  • Ridker PM, MacFadyen JG, Thuren T, et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis:...
  • Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under...
  • Plana JC, Galderisi M, Barac A, et al. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy:...
  • Pérez IE, Taveras Alam S, Hernández GA, et al. Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician. Clin Med Insights...
  • Lyon AR, Dent S, Stanway S, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies:...
  • Celutkien J, Pudil R, López-Fernández T, et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position...
  • Medvedofsky D, Mor-Avi V, Amzulescu M, et al. Three-dimensional echocardiographic quantification of the left-heart chambers using an automated...
  • Frey MK and Bergler-Klein J. Echocardiographic evaluation of patients undergoing cancer therapy. Eur Heart J Cardiovasc Imaging [Internet]....
  • Rosmini S, Aggarwal A, Chen DH, et al. Cardiac computed tomography in cardio-oncology: an update on recent clinical applications. Eur Heart...
  • Sawaya H, Sebag IA, Plana JC, et al. Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients...
  • Pudil R, Mueller C, Celutkiene J, et al. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement...
  • Chang HM, Moudgil R, Scarabelli T, et al. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management:...
  • Pareek N, Cevallos J, Moliner P, et al. Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience. Eur...
  • Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation...
  • Thavendiranathan P, Negishi T, Somerset E, et al. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. JACC [Internet]. 2021...
  • Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail...
  • Lancellotti P, Suter TM, López-Fernández T, et al. Cardio-Oncology Services: rationale, organization, and implementation. Eur Heart J [Internet]....